iPath Series B Bloomberg Softs Subindex Total ReturnSM ETN
JJS was delisted on the 7th of June, 2023.
2 hedge funds and large institutions have $3.1M invested in iPath Series B Bloomberg Softs Subindex Total ReturnSM ETN in 2019 Q3 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 0 closing their positions.
0% more funds holding
Funds holding: 2 → 2 (0)
54% less capital invested
Capital invested by funds: $6.77M → $3.1M (-$3.67M)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Barclays
London,
United Kingdom
|
-$3.1M |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$37 |
JJS Hedge Fund Activity: Q3 2019 in Review
2 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in iPath Series B Bloomberg Softs Subindex Total ReturnSM ETN (JJS) for Q3 2019, worth a combined $3.1M — down 54% from $6.77M a quarter earlier.
Fund positioning in JJS was balanced in Q3 2019: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 2 trimmed.
The largest seller was Barclays, cutting an estimated $3.1M.
- 2 institutional investors held iPath Series B Bloomberg Softs Subindex Total ReturnSM ETN (JJS) as of Q3 2019, unchanged from Q2 2019.
- Funds reported $3.1M of iPath Series B Bloomberg Softs Subindex Total ReturnSM ETN stock for Q3 2019, down 54% quarter-over-quarter.
- 0 funds opened new iPath Series B Bloomberg Softs Subindex Total ReturnSM ETN positions in Q3 2019 and 0 closed out.
- The largest iPath Series B Bloomberg Softs Subindex Total ReturnSM ETN seller in Q3 2019 was Barclays, an estimated $3.1M sold.
Based on aggregated 13F filings for Q3 2019.